The role of the CCAAT/enhancer-binding protein in the transcriptional regulation of the gene for phosphoenolpyruvate carboxykinase (GTP) - PubMed (original) (raw)
The role of the CCAAT/enhancer-binding protein in the transcriptional regulation of the gene for phosphoenolpyruvate carboxykinase (GTP)
E A Park et al. Mol Cell Biol. 1990 Dec.
Abstract
Previous studies have identified a region in the promoter of the gene for phosphoenolpyruvate carboxykinase (GTP) (PEPCK) (positions -460 to +73) containing the regulatory elements which respond to cyclic AMP, glucocorticoids, and insulin and confer the tissue- and developmental stage-specific properties to the gene. We report that CCAAT/enhancer-binding protein (C/EBP) binds to the cyclic AMP-responsive element CRE-1 as well as to two regions which have been previously shown to bind proteins enriched in liver nuclei. The DNase I footprint pattern provided by the recombinant C/EBP was identical to that produced by a 43-kDa protein purified from rat liver nuclear extracts, using a CRE oligonucleotide affinity column, which was originally thought to be the CRE-binding protein CREB. Transient contransfection experiments using a C/EBP expression vector demonstrated that C/EBP could trans activate the PEPCK promoter. The trans activation occurred through both the upstream, liver-specific protein-binding domains and the CRE. The CRE-binding protein bound only to CRE-1 and not to the upstream C/EBP-binding sites. The results of this study, along with physiological properties of C/EBP, indicate an important role for this transcription factor in providing the PEPCK gene with several of its regulatory characteristics.
Similar articles
- What is a cAMP response unit?
Roesler WJ. Roesler WJ. Mol Cell Endocrinol. 2000 Apr 25;162(1-2):1-7. doi: 10.1016/s0303-7207(00)00198-2. Mol Cell Endocrinol. 2000. PMID: 10854692 Review.
Cited by
- Coupling of binding and differential subdomain folding of the intrinsically disordered transcription factor CREB.
Bentley EP, Scholl D, Wright PE, Deniz AA. Bentley EP, et al. FEBS Lett. 2023 Apr;597(7):917-932. doi: 10.1002/1873-3468.14554. Epub 2022 Dec 19. FEBS Lett. 2023. PMID: 36480418 Free PMC article. - Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and mechanisms beyond gluconeogenesis.
Yu S, Meng S, Xiang M, Ma H. Yu S, et al. Mol Metab. 2021 Nov;53:101257. doi: 10.1016/j.molmet.2021.101257. Epub 2021 May 18. Mol Metab. 2021. PMID: 34020084 Free PMC article. Review. - Melatonin stimulates transcription of the rat phosphoenolpyruvate carboxykinase gene in hepatic cells.
Asano K, Tsukada A, Yanagisawa Y, Higuchi M, Takagi K, Ono M, Tanaka T, Tomita K, Yamada K. Asano K, et al. FEBS Open Bio. 2020 Dec;10(12):2712-2721. doi: 10.1002/2211-5463.13007. Epub 2020 Nov 2. FEBS Open Bio. 2020. PMID: 33070478 Free PMC article. - PEPCK1 Antisense Oligonucleotide Prevents Adiposity and Impairs Hepatic Glycogen Synthesis in High-Fat Male Fed Rats.
Beddow SA, Gattu AK, Vatner DF, Paolella L, Alqarzaee A, Tashkandi N, Popov VB, Church CD, Rodeheffer MS, Cline GW, Geisler JG, Bhanot S, Samuel VT. Beddow SA, et al. Endocrinology. 2019 Jan 1;160(1):205-219. doi: 10.1210/en.2018-00630. Endocrinology. 2019. PMID: 30445425 Free PMC article. - Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.
Ayyar VS, Sukumaran S, DuBois DC, Almon RR, Qu J, Jusko WJ. Ayyar VS, et al. J Pharmacokinet Pharmacodyn. 2018 Aug;45(4):557-575. doi: 10.1007/s10928-018-9585-x. Epub 2018 Apr 27. J Pharmacokinet Pharmacodyn. 2018. PMID: 29704219 Free PMC article.
References
- Mol Cell Biol. 1988 Jan;8(1):96-104 - PubMed
- Mol Cell Biol. 1990 May;10(5):2418-22 - PubMed
- J Biol Chem. 1988 Aug 15;263(23):11443-51 - PubMed
- J Biol Chem. 1988 Dec 25;263(36):19740-7 - PubMed
- Mol Cell Biol. 1988 Aug;8(8):3467-75 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources